openPR Logo
Press release

Clinical Nutrition Market is expected to register a CAGR of 5.8% during the forecast period, 2018 to 2023| Major Vendors – ABBOTT NUTRITION, NESTLE HEALTH SCIENCE, BAXTER HEALTHCARE, NUTRICIA, MEAD JOHNSON, amongst others

04-05-2019 12:45 PM CET | Health & Medicine

Press release from: Market Prognosis

Market Analysis:

Asia-Pacific to Dominate the Market Growth
Asia-Pacific is the largest geographical market, and is also expected to grow at a highest CAGR of 6.94%. China is the largest market segment of the Asia-Pacific region, valued at USD 7,290 million in the year 2017. However, India is the fastest growing segment of this region. And North America region is the next to the Asia-Pacific region.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16748
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Healthcare spending continues to grow faster than economic growth in most countries, maintaining a trend observed over decades. The presence of equitable, responsive, and efficient health systems across the countries of North America, Europe, United Kingdom, and Asia-Pacific has also contributed to the maximum share of GDP for healthcare expenditure. In 2014, the United States spent nearly USD 3 trillion on healthcare, with advanced healthcare facilities, high cost of treatments and high healthcare awareness being the major reasons. As the healthcare spending increases worldwide among major countries of the world, along with the prevalence of metabolic disorders, rising aging population and rise of middle class in the emerging economies are driving the clinical nutrition market. Marketing of clinical nutrition products is one major hurdle for the growth of the clinical nutrition market.

Request Discount on this report @ https://marketprognosis.com/discount-request/16748
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

Market Segments:
Clinical Nutrition Market is segmented by:
1. ROUTE OF ADMINISTRATION: ORAL, ENTERAL, PARENTERAL
2. DISEASE TYPE: NUTRITIONAL SUPPORT IN CANCER, IN GASTROINTESTINAL (GI) DISEASES, IN NEUROLOGICAL DISEASES, IN RENAL DISEASES, IN RESPIRATORY DISEASES, IN METABOLIC SYNDROMES, IN OTHER DISEASE AREAS
3. END USER: INFANT, CHILD, ADULT, GERIATRIC
4. Geography: North America, South America, Europe, Asia Pacific, Middle East & Africa

Key Developments in the Market
• January 2018: French dairy firm Lactalis has to recall millions of powdered milk products off the shelf after a salmonella scare at a French diary firm. This is expected to create opportunities for new entrants in the clinical nutrition market.
• January 2018: Fresenius Kabi and ASPEN (The American Society for Parenteral and Enteral Nutrition) are creating awareness among clinicians who provide nutrition support by launching video series that highlights the best practices for dosing, preparing and administering intravenous lipid emulsions (ILE).

Enquiry Before Buying @ https://marketprognosis.com/enquiry/16748
Note: “If this link doesn’t work in Internet Explorer, kindly try pasting it in other browsers.”

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Nutrition Market is expected to register a CAGR of 5.8% during the forecast period, 2018 to 2023| Major Vendors – ABBOTT NUTRITION, NESTLE HEALTH SCIENCE, BAXTER HEALTHCARE, NUTRICIA, MEAD JOHNSON, amongst others here

News-ID: 1690502 • Views:

More Releases from Market Prognosis

Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innovations and Foreseen Till 2026 | FedEx, Exel Logistics, Menlo Worldwide Logistics, Ryder Logistics
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Third-Party Logistics (3PL) Market: The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing by Top Key Players (Didi, Uber, Lyft, Gett, Hailo, Ola Cabs, Cabify, GoCatch) | Foreseen Till 2026
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Ride-Hailing Market: The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry Insight and Growth Strategy by Business Players - AIG, Chubb (ACE), Allianz, XL Group, AXA, Aviva
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Professional Indemnity Insurance Market: The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional
Modular Construction Market Future Growth Explored in Latest Research Report by 2026 | Komatsu, Kiewit, Skanska, L&T, Taisei, ACS Group, Bouygues Construction
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Modular Construction Market: The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It

All 5 Releases


More Releases for DISEASE

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and